ARTICLE | Clinical News
Prezista darunavir regulatory update
April 20, 2009 7:00 AM UTC
Health Canada approved an expanded label for once-daily Prezista darunavir from Johnson & Johnson to include use in combination with antiretroviral agents to treat HIV-1 infection in treatment-naive ...